Sort
15,842 grants matching “pancreatic cancer”
Single-cell phenotyping for therapeutic stratification in pancreatic cancer
$750,000Denis Wirtz · Johns Hopkins University · R01 · FY2014 · CA
Single-cell phenotyping for therapeutic stratification in pancreatic cancer
$750,000Denis Wirtz · Johns Hopkins University · R01 · FY2016 · CA
Single-cell phenotyping for therapeutic stratification in pancreatic cancer
$750,000Denis Wirtz · Johns Hopkins University · R01 · FY2013 · CA
CANCER AND INFLAMMATION: FUNCTION AND THERAPY
$749,761Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Physical Activity, Energy Balance, and Cancer
$749,585Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
$748,441Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2021 · CA
Dissecting the Source and Mechanisms of IL-17-Mediated Modulation of Pancreatic Tumorigenesis
$748,012Florencia McAllister · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
MODULATING NEURAL SIGNALING IN THE TREATMENT OF PANCREATIC CANCER
$747,935The Trustees Of Columbia University In The City Of New York · · FY2021 · Defense Health Agency
Clinical Resources Key Componient Activity
$747,234R Hal Scofield · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2016 · GM
Clinical Resources Key Componient Activity
$747,234R Hal Scofield · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2017 · GM
Clinical Resources Key Componient Activity
$747,234R Hal Scofield · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2014 · GM
Clinical Resources Key Componient Activity
$747,234R Hal Scofield · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2015 · GM
Antibody Therapy of Cancer
$747,016Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis
$746,660Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
$746,625William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Preclinical drug development in pancreas cancer
$746,546Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Building protected data sharing networks to advance cancer risk assessment and treatment
$746,402Ian Foster · University Of Chicago · U24 · FY2019 · CA
Understanding omega-3 and 6 fatty acid dependent regulation of inflammatory signals in pancreatic cancer
$745,320Susan M Kaech · Salk Institute For Biological Studies · U01 · FY2025 · CA
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)
$745,050Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2024 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$744,746Robert Kreitman · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Identification of synthetic lethal interactors in pancreatic cancer
$744,708Channing J Der · Univ Of North Carolina Chapel Hill · U01 · FY2015 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$744,686Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)
$744,400Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Using mouse models to probe the relationship of oncogenesis to development and o
$743,710Eric C Holland · Sloan-Kettering Inst Can Research · U01 · FY2011 · CA
Using mouse models to probe the relationship of oncogenesis to development and o
$743,706Eric C Holland · Sloan-Kettering Inst Can Research · U01 · FY2012 · CA